Clinical Trials · NCT00696644
A Study for Teriparatide in Severe Osteoporosis
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 794
- Start date
- Jun 2008
- Locations
- 1 site, Italy
- Primary endpoint
- Incidence of any osteoporotic fractures in the first 24 months from the initiation of anabolic medication.